Cargando…
A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients
Osteoporosis is a common progressive metabolic bone disease resulting in decreased bone mineral density (BMD) and a subsequent increase in fracture risk. The known bone markers are not sensitive and specific enough to reflect the balance in the bone metabolism. Finding a metabolomics-based biomarker...
Autores principales: | Aleidi, Shereen M., Alnehmi, Eman A., Alshaker, Mohammed, Masood, Afshan, Benabdelkamel, Hicham, Al-Ansari, Mysoon M., Abdel Rahman, Anas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466514/ https://www.ncbi.nlm.nih.gov/pubmed/34564444 http://dx.doi.org/10.3390/metabo11090628 |
Ejemplares similares
-
Proteomics Profiling of Osteoporosis and Osteopenia Patients and Associated Network Analysis
por: Al-Ansari, Mysoon M., et al.
Publicado: (2022) -
Lipidomics Profiling of Patients with Low Bone Mineral Density (LBMD)
por: Aleidi, Shereen M., et al.
Publicado: (2022) -
The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment
por: Jaber, Malak A., et al.
Publicado: (2022) -
Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus
por: Gu, Xinyun, et al.
Publicado: (2020) -
Proteomics Investigation of the Impact of the Enterococcus faecalis Secretome on MCF-7 Tumor Cells
por: Alwehaibi, Moudi A., et al.
Publicado: (2023)